A comparative retrospective study to evaluate the impact of covid-19 on ayushman bharat scheme (dkbssy) registration in cancer department at chhattisgarh institute of medical sciences, bilaspur, chhattisgarh

Background: Ayushman Bharat PM-JAY is the largest health assurance scheme in the world which aims at providing health cover of Rs 5 lakhs per family / year for secondary and tertiary care hospitalization to cover 10.74 crores poor and vulnerable families (approximately 50 crore beneficiaries) that form the bottom 40% of the Indian population. Ayushman Bharat Scheme or Pradhan Mantri Jan Arogya Yojna or PM-JAY was launched on 23rd September, 2018. In our state Chhattisgarh it is run as Dr. Khoobchand Baghel Swasthya Sahayata Yojna (DKBSSY). PM-JAY is fully funded by the Government and cost of implementation is shared between the Central and the State Governments. It provides cashless access to health care services for the beneficial at the point of all necessary services. Methods: This retrospective comparative clinical study is conducted in the department of Radiotherapy, Chhattisgarh Institute of Medical Sciences, Bilaspur, Chhattisgarh. The one year Ayushman Bharat scheme (DKBSSY) registration data from 20 March 2019 to 20 March 2020 is compared with the data from Covid-19 year from 20 March 2020 to 20 March 2021. Frequency tables, comparative charts are used to evaluate and measure the data from the study to describe the impact of Covid-19 on Ayushman Bharat scheme (DKBSSY) registration in cancer department Findings: In Pre Covid-19 yr the total Ayushman beneficiary registered in radiotherapy department, CIMS was (90.07%) IPD, patients of carcinoma ovary and cervix were registered 100%, followed by breast cancer (98.92%), head & neck cancer (98.83%), lung cancer (96.72%) and colorectal cancers (96.55%). In Covid-19 yr the total Ayushman beneficiary registered in radiotherapy department, CIMS was (96%) IPD, patients of carcinoma ovary, carcinoma cervix, carcinoma breast and carcinoma lung were registered 100%, followed by head & neck cancer (99.28%), colorectal cancer (98.91%) and haematological cancers (96%). Interpretation: We observed in our study that in Pre Covid-19 yr majority of the cancer IPD patients registered were old females and belonged to lower SES, in Covid-19 pandemic year there was slight increase in male and upper SES patients compared to pre Covid-19 year, a surge in IPD of 6% is seen in hematological malignancies and fall of 6% IPD of breast cancer is noted in Covid-19 pandemic year. The Ayushman registration noted in pre Covid-19 year was 90.07% with 100% registry of carcinoma ovary and cervix whereas in during the Covid-19 pandemic the Ayushman registration was 96% with 100% registration of carcinoma ovary, carcinoma cervix, carcinoma breast and carcinoma lung.